Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
1. What is lobular neoplasia?
2. Types of lobular neoplasia
3. Who lobular neoplasia affects
4. Diagnosing lobular neoplasia
5. Treating lobular neoplasia
6. Lobular neoplasia and breast cancer risk
8. Other important information
9. Further support
Lobular neoplasia is a benign (not cancer) condition.
Breasts are made up of lobules (milk-producing glands) and ducts (tubes that carry milk to the nipple). These are surrounded by tissue that gives breasts their size and shape.
Diagram showing the breast
When lobular neoplasia occurs, there’s an increase in the number of cells contained in the lobules and a change in their appearance and behaviour.
There are different types of lobular neoplasia. These are:
‘In situ’ means the changes only occur in the breast lobules and do not affect the surrounding breast tissue.
When tissue is examined under a microscope, ALH and classical LCIS can look very similar. It’s sometimes difficult to separate the two conditions and they may both be described as lobular neoplasia.
PLCIS is made up of larger, more abnormal cells.
Lobular neoplasia is most common in women aged 40–50, but it can be found in women of any age.
It can be found in men, but this is extremely rare.
Lobular neoplasia doesn’t usually cause any symptoms or show up on a mammogram.
It’s usually found during a biopsy or other test being done for another breast change. For example, when calcifications (small spots of calcium) are detected on a mammogram.
If lobular neoplasia is found by a core biopsy, your specialist may recommend removing more tissue from the area where the lobular neoplasia was found. This is to check if there are any cancer cells in this part of the breast.
This may be done using one of the following:
A mammogram or ultrasound scan may also be used to help identify the area. Your treatment team will talk to you about which procedure is best for you.
You will not usually need treatment for ALH and classical LCIS, but your specialist may discuss treatment options with you based on current guidelines and your individual situation.
If the biopsy shows PLCIS, your specialist may suggest an operation to remove the area with a margin (border) of healthy breast tissue. This is because of the higher risk of breast cancer with this type of lobular neoplasia. The operation will show if there are any cancer cells in the tissue, and if all the PLCIS has been removed.
Most women diagnosed with ALH or classical LCIS will never get breast cancer. However, there is a slightly higher risk than the general population of developing breast cancer in either breast.
Women diagnosed with PLCIS are more at risk of developing breast cancer than those with ALH or classical LCIS.
Your individual risk depends on several factors, which your specialist can discuss with you.
However, any possible benefit of taking tamoxifen needs to be considered against the risks and side effects of this treatment. Your specialist will discuss with you if this might be an option.
Your specialist will usually recommend having yearly follow-up mammograms for up to five years.
If you have other risk factors for breast cancer, such as a significant family history, scans may be recommended, such as an MRI (magnetic resonance imaging) scan. Your specialist will discuss which follow-up is best for you.
HRT and oral contraceptives are not usually recommended for people after a diagnosis of lobular neoplasia.
Finding out that you have lobular neoplasia can leave you feeling different emotions. Fear, shock and anger are all common feelings. Although lobular neoplasia is not breast cancer, it can cause uncertainty about your future risk of breast cancer and you may feel anxious.
If you’re worried about breast cancer or have a question about lobular neoplasia, our specialist team are ready to listen on our free Helpline.